Management strategies for subarachnoid hemorrhage (SAH) include early aneurysm obliteration, pharmacologic prevention of vasospasm, therapeutic (but not prophylactic) hyperdynamic therapy, targeted critical care, and rehabilitation. Despite recent advances, major gaps in our knowledge remain, and many potentially salvageable patients have devastating outcomes. Neuroprotective, prognostic, and pharmacologic developments are especially promising. This chapter highlights areas of intensive study in SAH management, with hopes that the efforts of dedicated clinician-scientists will come to fruition in the near future. I mean to highlight promising areas of active study with preliminary data or research funding, not today's state-of-the-art. There are no express or implied guarantees about actual progress.
ASJC Scopus subject areas